⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27483808 | 0.97 | CES2 (0.41) | — | |
| SCHEMBL27548546 | 0.97 | CES2 (0.41) | — | |
| SCHEMBL27467975 | 0.97 | CES2 (0.41) | — | |
| SCHEMBL27484131 | 0.97 | CES2 (0.41) | — | |
| Water SCHEMBL27553997 | 0.95 | CES2 (0.39) | — | |
| Water SCHEMBL27467035 | 0.95 | CES2 (0.39) | — | |
| Water SCHEMBL27467037 | 0.95 | CES2 (0.39) | — | |
| Water SCHEMBL27483809 | 0.93 | FBP1 (0.40) | — | |
| SCHEMBL1001159 | 0.78 | CA1 (0.43) | — | |
| SCHEMBL7696615 | 0.76 | CA1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1080096-B1 | NOVEL FURYLPHOSPHINES AND ORGANOMETALLIC COMPLEXES CONTAINING THEM | RHODIA POLYAMIDE INTERMEDIATES (FR) | 2003-04-09 | — | — | EP | claimed |
| US-6417375-B1 | ISOMERIZATION OF 2-METHYL-3-BUTENENITRILE TO 3-PENTENENITRILE; HYDROGENATION, DIMERIZATION, HYDROFORMYLATION, HYDROCYANATION, TELOMERIZATION, AND POLYMERIZATION CATALYSTS | RHODIA FIBER & RESIN INTERMEDIATES (FR) | 2002-07-09 | — | — | US | claimed |
| US-20250133947-A1 | Thermal Evaporation-Growth of Halide Perovskites Through Phosphonic Acid Addition | GEORGIA TECH RES INST (US) | 2025-04-24 | — | — | US | disclosed |
| CN-110357842-B | Fluoroalkyl substituted furan compound and preparation method thereof | 南京工业大学 | 2022-12-16 | — | — | CN | disclosed |
| CN-110357842-A | Fluoroalkyl substituted furan compound and preparation method thereof | 南京工业大学 | 2019-10-22 | — | — | CN | disclosed |
| EP-1060182-B1 | NOVEL PRODRUGS FOR PHOSPHORUS-CONTAINING COMPOUNDS | METABASIS THERAPEUTICS INC (US) | 2012-12-19 | — | — | EP | disclosed |
| US-7635748-B2 | Resin and article molded therefrom | TORAY INDUSTRIES, INC. (JP) | 2009-12-22 | — | — | US | disclosed |
| US-20090192121-A1 | NOVEL BISAMIDATE PHOSPHONATE PRODRUGS | JIANG TAO | 2009-07-30 | — | — | US | disclosed |
| EP-1270646-B1 | RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM | TORAY INDUSTRIES (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-7442757-B2 | Resin, resin composition, method for manufacturing the same, and molded material including the same | TORAY INDUSTRIES, INC. (JP) | 2008-10-28 | — | — | US | disclosed |
| US-20080139778-A1 | Resin and article molded therefrom | TAKANISHI KEIJIRO | 2008-06-12 | — | — | US | disclosed |
| EP-1270646-A1 | RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM | TORAY INDUSTRIES, INC. (JP) | 2003-01-02 | — | — | EP | disclosed |
| US-6489476-B1 | FRUCTOSE-1,6-BISPHOSPHATASE ENZYME INHIBITORS ARE USEFUL IN THE TREATMENT OF DIABETES AND OTHER CONDITIONS ASSOCIATED WITH ELEVATED BLOOD GLUCOSE OR EXCESS GLYCOGEN STORAGE. | METABASIS THERAPEUTICS, INC. | 2002-12-03 | — | — | US | disclosed |
| US-20020173490-A1 | Novel bisamidate phosphonate prodrugs | METABASIS THERAPEUTICS, INC. | 2002-11-21 | — | — | US | disclosed |
| EP-1143955-A3 | A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES | Metabasis Therapeutics Inc. (US) | 2002-08-28 | — | — | EP | disclosed |
| US-6417375-B1 | ISOMERIZATION OF 2-METHYL-3-BUTENENITRILE TO 3-PENTENENITRILE; HYDROGENATION, DIMERIZATION, HYDROFORMYLATION, HYDROCYANATION, TELOMERIZATION, AND POLYMERIZATION CATALYSTS | RHODIA FIBER & RESIN INTERMEDIATES (FR) | 2002-07-09 | — | — | US | disclosed |
| EP-1143955-A2 | A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES | Metabasis Therapeutics Inc. (US) | 2001-10-17 | — | — | EP | disclosed |
| EP-1060182-A2 | NOVEL PRODRUGS FOR PHOSPHORUS-CONTAINING COMPOUNDS | Metabasis Therapeutics, Inc. (US) | 2000-12-20 | — | — | EP | disclosed |
| WO-2000038666-A2 | A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES | METABASIS THERAPEUTICS, INC. (US) | 2000-07-06 | — | — | WO | disclosed |
| WO-1999045016-A2 | NOVEL PRODRUGS FOR PHOSPHORUS-CONTAINING COMPOUNDS | METABASIS THERAPEUTICS, INC. (US) | 1999-09-10 | — | — | WO | disclosed |